Pharmaceuticals Directory Resources

Add URL Pharmaceuticals

Pharmaceuticals News

Celator Pharmaceuticals Receives Orphan Drug Designation For Anticancer Agent CPX-351 (Medical News Today)

Celator Pharmaceuticals announced that the U.S. Food & Drug Administration (FDA) has granted orphan drug designation to CPX-351 (Cytarabine:Daunorubicin) Liposome Injection for the treatment of Acute Myeloid Leukemia (AML). Celator is currently preparing to conduct two randomized Phase 2 studies with CPX-351.

ACADIA Pharmaceuticals Files Registration Statement as Required by Previously Announced Committed Equity Financing ... (wallstreet:online AG)

ACADIA Pharmaceuticals Inc. (3545;Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology

Rexahn Pharmaceuticals expands cancer patent portfolio (BizJournals)

Rexahn Pharmaceuticals Inc. has secured a new cancer patent that will further its efforts to develop cancer treatments.

ACADIA Pharmaceuticals Files Registration Statement as Required by Previously Announced Committed Equity Financing ... (Centre Daily Times)

ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it filed a registration statement as required under the terms of its previously announced Committed Equity Financing Facility (CEFF) with Kingsbridge Capital Limited.

Early Glance: Pharmaceuticals companies (INO News)

(AP:NEW YORK) Shares of some top pharmaceuticals companies are mixed at 10 a.m.: Bristol-Myers Squibb fell $.16 or .7 percent, to $21.34. Hospira fell $.83 or 2.1 percent, to $38.61.